Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
A Shanghai Chest Hospital trial is evaluating robotic-assisted sleeve lobectomy after neoadjuvant chemoimmunotherapy for stage IIB to III no…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors [Phase 1]
Phase I study update for the radiopharmaceutical [177Lu]Lu-DFC413 in patients with various solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer [NA]
A University of Arizona-sponsored clinical trial is evaluating how exercise impacts the tumor microenvironment in patients with non-small ce…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013) [Phase 3]
A Phase 3 trial evaluating pembrolizumab (MK-3475A) with or without Calderasib (MK-1084) in completely resected KRAS G12C-mutant non-small c…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating first-line olomorasib with pembrolizumab, with or without chemotherapy, in advanced KRAS G12C-mutant non-small ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation [Phase 1, Phase 2]
This is an ongoing Phase 1/2 clinical trial evaluating divarasib as a single agent or in combination with other anti-cancer therapies in pre…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04) [Phase 3]
A Phase 3 clinical trial update describing a study of BL-B01D1 in combination with Osimertinib versus Osimertinib alone as first-line treatm…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer [NA]
A clinical trial update notes a neoadjuvant regimen of Iparomlimab and Tuvonralimab plus chemotherapy before surgery for stage III non-small…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and efficacy of BLEX 404 oral liquid in combination with pemetrexed and cisplatin for no…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing [Phase 1]
Phase 1 clinical trial investigating therapeutic drug monitoring-based dosing of atezolizumab across multiple cancers, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
Eli Lilly's LY4050784 is being studied in a Phase 1 trial for advanced or metastatic solid tumors and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab [Phase 1]
A Phase 1 clinical trial evaluating how BI 765063 and BI 770371 are taken up in tumors of patients with advanced cancers who are receiving e…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC) [Phase 3]
A Phase 3 trial comparing RC148 plus platinum-based chemotherapy versus tislelizumab plus platinum-based chemotherapy for first-line squamou…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers [Phase 1, Phase 2]
Pfizer is conducting Phase 1/2 trials to evaluate PF-08634404 in combination with different anticancer agents for advanced non-small cell lu…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial update for a Phase 1/Phase 2 study of SHR-A1811 in combination with Pyrotinib or SHR-1316 in adults with advanced non-small…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors [Phase 1]
Phase 1 clinical trial update showing LY4052031 being studied in advanced or metastatic urothelial cancer and other solid tumors; the study …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for telisotuzumab vedotin in combination with osimertinib for progressive non-small cell lung cancer, currentl…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1. [Phase 3]
A Phase 3 clinical trial update on the combination of Sigvotatug Vedotin and pembrolizumab in people with non-small cell lung cancer express…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Sigvotatug Vedotin in Advanced Solid Tumors [Phase 1]
Phase 1 study of Sigvotatug Vedotin in advanced solid tumors is currently recruiting. The trial targets multiple indications, including non-…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating SGN-CEACAM5C in adults with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer [Phase 2]
This clinical trial update reports on a Phase 2 study evaluating a single dose of LS301-IT for fluorescence intraoperative molecular imaging…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors [Phase 1]
A Phase 1 study evaluating the safety and potential early efficacy of NST-628 oral tablets in adults with solid tumors is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Dabrafenib and/or Trametinib Rollover Study [Phase 4]
Phase 4 rollover study of dabrafenib and/or trametinib for melanoma and non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Real-Time Imaging to Improve Lung Cancer Diagnosis : Comparing Confocal Laser Endomicroscopy (CLE) With Standard Biopsy for Quicker and Safer Detection of Non-Small Cell Lung Cancer
A study is evaluating real-time confocal laser endomicroscopy versus standard biopsy to speed and improve safety of detecting Non-Small Cell…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. [Phase 1]
Pfizer is conducting a Phase 1 study of PF-07934040 in adults with advanced solid tumors carrying a genetic mutation, evaluating the drug al…